.@Nasdaq #TradeTalks: New Approach to the Treatment of Alzheimer’s Disease @Cortexyme @JillMaland...

COR388: a novel approach to treating Alzheimer’s based on the gingipain hypothesisПодробнее

TradeTalks: Therapies designed to modify Parkinson’s Disease in the brain and GI tractПодробнее

.@Nasdaq #TradeTalks: Save, Budget, InvestПодробнее

Jim Cramer on FDA resignations connected to the approval of Biogen’s Alzheimer’s drugПодробнее

Alzheimer's Disease - One Step Closer to Finding a CureПодробнее

Vaccine for Alzheimer's DiseaseПодробнее

.@Nasdaq #TradeTalks: Intersection of Technology & Policy Making @EdFelten @Princeton @JillMaland...Подробнее

#TradeTalks: Why women are disproportionately impacted by Alzheimer’s #WAMПодробнее

.@Nasdaq #TradeTalks: Intelligent Investing – Having the Right Process @NvstrOfficial @JillMaland...Подробнее

Breakthrough Economy: How Biotech is Transforming Mental Health and Neurological DisordersПодробнее

#TradeTalks: Accelerating the Development of a Treatment for COVID-19Подробнее

FALCON siRNA Therapies to Help Patients With Ocular, Neuromuscular, and CNS DiseasesПодробнее

"Improving White Matter Integrity In Alzheimer's Disease" INmune Bio (NASDAQ:INMB) CEO & CFO 9-3-21Подробнее

VentureFuel on Nasdaq TradeTalksПодробнее

Breakthrough Economy: Exploring Innovative Therapies in Immuno-OncologyПодробнее

The Smart Money Are Looking At Cortexyme IncПодробнее

FDA approves much-debated Alzheimer’s drug panned by expertsПодробнее

6/11/2019 - Session 1 Part A: LynchПодробнее